UK markets closed

Kezar Life Sciences, Inc. (KZR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.8523-0.0024 (-0.28%)
As of 12:21PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-64,270
-101,870
-68,239
-54,630
-41,742
Depreciation & amortisation
1,693
1,066
1,023
1,510
1,544
Stock-based compensation
12,042
18,137
14,006
7,596
4,943
Change in working capital
-4,034
4,706
-4,459
1,226
-2,011
Other working capital
-55,545
-83,455
-60,424
-42,753
-37,143
Other non-cash items
238
238
224
91
-
Net cash provided by operating activities
-54,044
-81,645
-58,846
-42,437
-36,949
Cash flows from investing activities
Investments in property, plant and equipment
-1,501
-1,810
-1,578
-316
-194
Purchases of investments
-351,860
-180,399
-332,203
-156,378
-225,728
Sales/maturities of investments
188,139
258,250
242,389
128,250
169,424
Net cash used for investing activities
-165,222
76,046
-91,392
-28,444
-56,498
Cash flows from financing activities
Common stock issued
217,180
0
126,542
100,970
99,186
Net cash used provided by (used for) financing activities
226,711
638
127,861
112,585
99,642
Net change in cash
7,359
-4,963
-22,426
41,654
6,277
Cash at beginning of period
57,094
40,456
62,882
21,228
14,951
Cash at end of period
64,539
35,493
40,456
62,882
21,228
Free cash flow
Operating cash flow
-54,044
-81,645
-58,846
-42,437
-36,949
Capital expenditure
-1,501
-1,810
-1,578
-316
-194
Free cash flow
-55,545
-83,455
-60,424
-42,753
-37,143